Australian Genomics is adapting to the COVID-19 situation and making changes to support the continuation of our research programs.
You might be an accomplished specialist in your medical field but how prepared are you for the next big wave in clinical medicine: genomics? That’s the question Australian Genomics researchers have been asking in interviews and a national survey.
Scientific collaboration, including data sharing systems, will be crucial in tackling rare diseases, which affect about 10 per cent of the global population, according to a new World Economic Forum paper.
People with heart conditions will have a higher chance of early diagnosis and targeted treatment, with a $6 million funding injection from the Federal Government’s Genomics Health Futures Mission.
What happens when the technological breakthroughs underpinning genomics research collide with sometimes wildly different healthcare systems, limited financial resources, differing attitudes to DNA testing, and growing community concerns over data privacy?
Activity under Massimo's Mission is well underway. Building on the existing clinical and research infrastructure of the Flagship, the program aims to solve more leukodystrophies through genomic sequencing, disease modelling and pre-clinical testing of targeted therapies.